Ranran Shi

743 total citations
25 papers, 302 citations indexed

About

Ranran Shi is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ranran Shi has authored 25 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ranran Shi's work include Cancer Cells and Metastasis (4 papers), Chemical Synthesis and Analysis (3 papers) and Ion Transport and Channel Regulation (2 papers). Ranran Shi is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Chemical Synthesis and Analysis (3 papers) and Ion Transport and Channel Regulation (2 papers). Ranran Shi collaborates with scholars based in China, United States and Italy. Ranran Shi's co-authors include Shunzeng Lv, Shigang Zhao, Yuting Liu, Fei Li, Hua Tian, Zhigeng Zou, Kun Mu, Xiangshan Yang, Yan Wang and Xingchen Zhou and has published in prestigious journals such as Diabetes, Scientific Reports and Industrial & Engineering Chemistry Research.

In The Last Decade

Ranran Shi

22 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranran Shi China 11 125 71 68 43 36 25 302
Pengcheng Luo China 12 152 1.2× 70 1.0× 77 1.1× 37 0.9× 42 1.2× 26 351
Tania Tsatralis Australia 10 191 1.5× 40 0.6× 79 1.2× 52 1.2× 37 1.0× 11 335
Mutsushi Yamasaki Japan 11 190 1.5× 89 1.3× 106 1.6× 77 1.8× 27 0.8× 29 414
Yurie Soejima Japan 12 125 1.0× 62 0.9× 59 0.9× 82 1.9× 27 0.8× 33 355
Xiaoqing Su China 11 135 1.1× 66 0.9× 78 1.1× 24 0.6× 44 1.2× 20 287
Xiumei Guan China 12 178 1.4× 45 0.6× 50 0.7× 37 0.9× 50 1.4× 25 346
Jia-Hong Chen Taiwan 11 180 1.4× 118 1.7× 73 1.1× 47 1.1× 27 0.8× 29 383
Brigitte Grouix Canada 9 105 0.8× 40 0.6× 34 0.5× 28 0.7× 36 1.0× 35 279
Yanwei Ye China 10 181 1.4× 74 1.0× 93 1.4× 29 0.7× 31 0.9× 23 315
Yasuhisa Naito Japan 12 169 1.4× 79 1.1× 46 0.7× 37 0.9× 26 0.7× 21 368

Countries citing papers authored by Ranran Shi

Since Specialization
Citations

This map shows the geographic impact of Ranran Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranran Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranran Shi more than expected).

Fields of papers citing papers by Ranran Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranran Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranran Shi. The network helps show where Ranran Shi may publish in the future.

Co-authorship network of co-authors of Ranran Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ranran Shi. A scholar is included among the top collaborators of Ranran Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranran Shi. Ranran Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Ranran, Ling Ran, Beibei Li, et al.. (2025). Comprehensive analysis of SELPLG as a potential immunotherapy target and prognostic biomarker in oncology. Discover Oncology. 16(1). 1073–1073.
3.
Shi, Ranran, et al.. (2025). Unraveling the Mechanism of Trimerization Reaction of Hexamethylene Diisocyanate: DFT Calculation and Experiments. Industrial & Engineering Chemistry Research. 64(24). 11888–11901.
4.
Li, Yang, Beibei Li, Qingchao Wang, et al.. (2024). Dual targeting of TIGIT and PD-1 with a novel small molecule for cancer immunotherapy. Biochemical Pharmacology. 223. 116162–116162. 7 indexed citations
5.
Shi, Ranran, Jie Jiang, Baohong Wang, et al.. (2023). Dynamic Screening of Thyroid Function for the Timely Diagnosis of Congenital Hypothyroidism in Very Preterm Infants: A Prospective Multicenter Cohort Study. Thyroid. 33(9). 1055–1063. 1 indexed citations
6.
Yu, Yue, et al.. (2020). New thymol and isothymol derivatives from Eupatorium fortunei and their cytotoxic effects. Bioorganic Chemistry. 98. 103644–103644. 14 indexed citations
7.
Xu, Chao, Yanping Li, Yan Pan, et al.. (2019). Presence of serum autoantibodies to vacuolar H+‐ATPase in patients with renal tubular acidosis. International Journal of Rheumatic Diseases. 22(5). 805–814. 3 indexed citations
9.
Shi, Ranran, Zhijian Fu, Tao Sun, et al.. (2017). Confirmation of the pathogenicity of a mutation p.G337C in the COL1A2 gene associated with osteogenesis imperfecta. Medicine. 96(39). e7783–e7783. 1 indexed citations
10.
Shi, Ranran, Congcong Li, Jin Xu, et al.. (2017). [Clinical and genetic characteristics of Gitelman syndrome in 5 pedigrees].. PubMed. 56(2). 104–111. 3 indexed citations
11.
Liu, Rui, Haitao Wang, Baofeng Xu, et al.. (2016). Cerebrovascular Safety of Sulfonylureas: The Role of KATP Channels in Neuroprotection and the Risk of Stroke in Patients With Type 2 Diabetes. Diabetes. 65(9). 2795–2809. 56 indexed citations
12.
Yuan, Lei, et al.. (2015). [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].. PubMed. 67(6). 611–7. 2 indexed citations
13.
Yang, Xiangshan, Ranran Shi, & Jing Zhang. (2015). Co-expression and clinical utility of Snail and N-cadherin in papillary thyroid carcinoma. Tumor Biology. 37(1). 413–417. 15 indexed citations
14.
Gan, Yandong, Ningning Dang, Zhenzhen Qu, et al.. (2015). GLP-1-Exendin-4/IgG4 (Fc) Fusion Protein as a Novel Drug for Diabetes Treatment. Experimental and Clinical Endocrinology & Diabetes. 123(6). 371–375. 10 indexed citations
15.
Yang, Xiangshan, et al.. (2014). The clinical implications of Crk-like adaptor protein expression in papillary thyroid microcarcinoma. Tumor Biology. 35(12). 12435–12440. 3 indexed citations
16.
Lv, Shunzeng, Bowen Sun, Xiao Yan Zhong, et al.. (2014). The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis. Molecular Neurobiology. 52(1). 555–561. 12 indexed citations
17.
18.
Lv, Shunzeng, Congxin Dai, Yuting Liu, et al.. (2014). Cell Surface Protein C23 Affects EGF-EGFR Induced Activation of ERK and PI3K-AKT Pathways. Journal of Molecular Neuroscience. 55(2). 519–524. 18 indexed citations
19.
Shi, Ranran, et al.. (2009). Kinetics of Resin-Supported Mitsunobu Esterification and Etherification Reactions. Journal of Combinatorial Chemistry. 11(3). 438–445. 4 indexed citations
20.
Yan, Bing, et al.. (2007). A Kinetic Study of Product Cleavage Reactions from the Solid Phase by a Biocompatible and Removable Cleaving Reagent, HCl. Journal of Combinatorial Chemistry. 9(4). 684–689. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026